Permanent Discontinuation of Tyrosine Kinase Inhibitor Frontline Therapy in Patients with Chronic Phase Chronic Myeloid Leukemia Patients during the First 36 Months of Treatment: A "Campus CML" Study

Mulas, O;Caocci, G;Specchia, G;
2022-01-01
2022
Inglese
BLOOD
140
Supplement 1
3906
3907
2
WOS:000893223203418
Esperti anonimi
scientifica
Goal 3: Good health and well-being
no
266
1 Contributo su Rivista::1.5 Abstract in rivista
info:eu-repo/semantics/article
1.5 Abstract in rivista
none
Latagliata, R; Capodanno, I; Miggiano, Mc; Iurlo, A; Cavazzini, F; Crescenzi, Sl; Russo, S; Carmosino, I; Bernardelli, A; Mulas, O; Elena, C; Binotto, ...espandi
29
Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie